Trial Profile
Analysis of genome and blood components for elucidation and treatment on dementia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2013
Price :
$35
*
At a glance
- Drugs Fluvoxamine (Primary) ; Risperidone (Primary) ; TJ 54 (Primary)
- Indications Dementia
- Focus Therapeutic Use
- 14 Aug 2013 Status changed from recruiting to completed, based on publication of results.
- 14 Aug 2013 Results published in the Journal of Clinical Psychopharmacology.
- 13 Aug 2011 New trial record